M. Robert Cooper

9.8k citations
144 papers · 7.8k · 4 hit papers · h-index 39

Impact in

  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Screening and Detection
    • Cancer survivorship and care
    • Breast Cancer Treatment Studies

Papers in

M. Robert Cooper

142 papers receiving 7.2k citations

M. Robert Cooper's Hit Papers

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer 2003 · 976 citations
9760+14+28Years since publication250500750

Peers

M. Robert Cooper
Comparison fields: 5 of 149
  • Oncology 2.9k
  • Cancer Research 1.4k
  • Hematology 1.0k
  • Pathology and Forensic Medicine 1.5k
  • Genetics 751
Replace Martin D. Abeloff with:
Martin D. Abeloff United States
Thomas E. Moon United States
Michael Lishner Israel
Martin M. Oken United States
Jourik A. Gietema Netherlands
Muhammad Wasif Saif United States
Diana Giannarelli Italy
Harvinder S. Luthra United States
Kenneth M. Boucher United States
Thomas C. Shea United States
M. Robert Cooper relative to Martin D. Abeloff United States Martin D. Abeloff's profile →
Citations per field
00.5×
Martin D. Abeloff · 1×
Citations per year

Countries citing papers authored by M. Robert Cooper

Since Specialization
Citations

This map shows the geographic impact of M. Robert Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Robert Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Robert Cooper more than expected).

Fields of papers citing papers by M. Robert Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Robert Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Robert Cooper. The network helps show where M. Robert Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Robert Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Robert Cooper Line = papers co-authored together M. Robert Cooper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
Hit paper breakdown →
2003976
2
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
Hit paper breakdown →
1992871
3
Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas
Hit paper breakdown →
2000715
4
Familial protein S deficiency is associated with recurrent thrombosis.
Hit paper breakdown →
1984514
5 1989291
6 2002248
7 2001214
8 1972195
9 1970158
10 1991145
11 1992132
12 1979100
13
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.
199693
14 198585
15 197880
16 199378
17
Pharmacokinetics of vincristine sulfate in adult cancer patients.
198177
18 199876
19 199375
20 200274

About M. Robert Cooper

M. Robert Cooper is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Hematology and Molecular Biology, having authored 144 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Lymphoma Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (16 papers), Lung Cancer Treatments and Mutations (13 papers), Breast Cancer Treatment Studies (11 papers), Lung Cancer Research Studies (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (2.9k citations), Cancer Research (1.4k citations), Hematology (1.0k citations), Pathology and Forensic Medicine (1.5k citations) and Genetics (751 citations). M. Robert Cooper has collaborated with scholars based in United States, Malaysia and Switzerland. Frequent co-authors include Lawrence R. DeChatelet, Hyman B. Muss, Charles L. Spurr, Charles T. Esmon, Randal R. Nixon, P C Comp, George P. Canellos, James R. Anderson, Edward S. Henderson and Frederick Richards. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Clinical Chemistry, Infection and Immunity and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact